Fig. 2From: Trastuzumab and fulvestrant combination therapy for women with advanced breast cancer positive for hormone receptor and human epidermal growth factor receptor 2: a retrospective single-center studyOverall survival in all patients. Kaplan–Meier curve of OS of fulvestrant and trastuzumab combination therapy in patients with hormone receptor- and human epidermal growth factor receptor 2-positive metastatic breast cancerBack to article page